Lupus Clinical Trials in Phoenix

Showing 141-160 of 193 trials

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

NCT02391259

This is a multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study in which approximately 56 subjects with SLE will be enrolled in 7 dosing cohorts

Systemic Lupus Erythematosus

Amgen57 participantsStarted Nov 2006

Anniston, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +10 more locations

TERMINATEDPhase 39.5 miles

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

NCT00381810

This is a Phase II/III open label, single-arm, multicenter, extension study to evaluate the safety and efficacy of rituximab when administered on a scheduled basis every 6 months over the course of 1 year with reassessment of response at 12 months. This study is open to participants previously enrolled in Genentech Study U2971g only.

Lupus Erythematosus, Systemic

Genentech, Inc.31 participantsStarted Jun 2006

Paradise Valley, Arizona, United States • San Leandro, California, United States • Boise, Idaho, United States +8 more locations

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Lupus Trials in Other Cities

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Validation of Ambulatory Sleep Test (WP200/U) Compared In-lab Sleep Testing in Cardiac Subjects

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Health-related Quality of Life Measure in Pediatric Lupus

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

Functional MRI in Lupus Nephritis

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Extended Follow-Up After Islet Transplantation in T1D

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Other Conditions in Phoenix